Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease

Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease

IntroductionParkinson’s disease (PD) is the second most common, progressive, and debilitating neurodegenerative disease associated with aging and the most common movement disorder. Photobiomodulation (PBM), the use of non-thermal light for therapeutic purposes using laser or light emitting diodes (L...

Full description

Bibliographic Details
Main Authors: Claire McGee, Ann Liebert, Geoffrey Herkes, Brian Bicknell, Vincent Pang, Craig S. McLachlan, Hosen Kiat
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Neuroscience
Subjects:
photobiomodulation
transcranial
Parkinson’s disease
cognitive dysfunction
mobility
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2022.945796/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2022.945796/full

Similar Items